Randomised evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia

Health Technology Assessment

Volumn 9, Issue 4, 2005, Pages

  Fowler, C ^a   McAllister, W ^a   Plail, R ^b   Karim, O ^c   Yang, Q ^d  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b East Sussex Healthcare NHS Trust   (United Kingdom)

^c WEXHAM PARK HOSPITAL   (United Kingdom)

^d SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROLYTE; HEMOGLOBIN; UREA;

AGED; ARTICLE; BLADDER NECK STENOSIS; BLOOD CELL COUNT; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; CLINICAL EXAMINATION; CLINICAL OBSERVATION; CLINICAL PRACTICE; CLINICAL TRIAL; CONTINENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; DISEASE SEVERITY; DISPOSABLE EQUIPMENT; EJACULATION DISORDER; ELECTRODE; ELECTROSURGERY; ERECTILE DYSFUNCTION; FOLLOW UP; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; INCIDENCE; INFORMATION PROCESSING; INTERMETHOD COMPARISON; LENGTH OF STAY; LITHOTRIPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL AUDIT; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDICAL SOCIETY; MICTURITION; MORBIDITY; MULTICENTER STUDY; NATIONAL HEALTH SERVICE; ORGAN SIZE; OUTPATIENT CARE; POSTAL MAIL; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PROSTATE; PROSTATE DISEASE; PROSTATE HYPERTROPHY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RECYCLING; SCORING SYSTEM; SEXUAL FUNCTION; SURGICAL EQUIPMENT; SURGICAL TECHNIQUE; SYMPTOM; TRANSURETHRAL ELECTROVAPORIZATION; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; UNITED KINGDOM; URETHRA SURGERY; URETHROTOMY; URINARY TRACT FUNCTION; URINE FLOW RATE; URINE VOLUME; METHODOLOGY; REVIEW; URINE RETENTION;

AGED; ELECTROSURGERY; ENGLAND; HUMANS; MALE; PROSTATIC HYPERPLASIA; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME; URINARY RETENTION;

EID: 14944380013     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta9040     Document Type: Article

References (41)

1. Drummond MF, McGuire AJ, Black NA, Petticrew M, McPherson CK. Economic burden of treated benign prostatic hyperplasia in the United Kingdom. Br J Urol 1993;71:290-6.
2. Britton JP, Dowell AC, Whelan P. Prevalence of urinary symptoms in men over 60. Br J Urol 1990;66:175-6.
3. Roos NP, Wennberg JE, Malenka DJ, Fisher ES, McPherson K, Andersen TF, et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Medi 1989;320:1120-4.
4. Mebust WK, Holtgrewe HL, Cocket ATK, Peters PC. Transurethral prostatectomy: immediate and post-operative complication. A cooperative study of 13 institutions evaluating 3885 patients. J Urol 1989; 141:243-7.
5. Neal DE. The National Prostatectomy Audit. Br J Urol 1997;79 Suppl. 2:69-73.
6. Dunsmuir WD, Emberton M. Surgery, drugs and the male orgasm. BMJ 1997;14:319-20.
7. Kramalowsky EV, Tucker RD. The urological application of electrosurgery. J Urol 1991; 146:669-74.
8. Bush MI, Malters E, Bush J. Transurethral vaporisation of the prostate: new horizons. Vol. 2. Berlin: Society for Minimally Invasive Therapy; 1993. p. 98.
9. Narayan P, Tewari A, Croker B, Garzotto M, Mustafa S, Jones T, et al. Factors affecting the size and configuration of electrovaporisation lesions in the prostate. Urology 1996; 47 679-88.
10. Lim LM, Ryan TP, Patel A. Factors influencing electrovaporization in the treatment of benign prostatic hyperplasia. Biomed Sci Instrum 1996; 32:197-204.
11. Kaplan SA, Te AE. Transurethral electrovaporisation of the prostate (TVP): an advance in electrosurgery for benign prostatic hyperplasia. Urology 1995;45:566-72.
12. Kaplan SA, Te AE. A comparative study of transurethral resection of the prostate using a modified electro-vaporising loop and transurethral laser vaporisation of the prostate. J Urol 1995; 154:1785-90.
13. Ekengren J, Hahn RG. Complications during TUVP. Urology 1996;48:424-7.
14. Patel A, Fuchs GJ, Gutierrez-Aceves J, Ryan TP. Prostate heating patterns comparing electrosurgical transurethral resection and vaporization: a prospective randomized study. J Urol 1997; 157 169-72.
15. Gerber GS, Jahoda A, Bales GT, Albala DM. Transurethral vaporization of the prostate in the treatment of bladder outlet obstruction at two university hospitals. Tech Urol 1997;3 25-9.
16. Matos-Ferreira A, Varregoso J. Electrovaporization of the prostate in patients with benign prostatic enlargement. Br J Urol 1997;80:575-8.
17. Chen SS, Chiu AW, Lin AT, Chen KK, Chang LS. Clinical outcomes at 3 months after transurethral vaporisation of the prostate for benign prostatic hyperplasia. Urology 1997;50:235-8.
18. Cetinkaya M, Ulusoy E, Adsan O, Ozturk, Basay S. Comparative early results of transurethral electroresection and transurethral vaporisation in benign prostatic hyperplasia. Br J Urol 1997; 78 901-3.
19. Kupeli S, Baltaci S, Soygur T, Aytac S, Yilmaz E, Budak M. A prospective randomized study of transurethral resection of the prostate and transurethral vaporization of the prostate as a therapeutic alternative in the management of men with BPH. Eur Urol 1998; 34 15-18.
20. Gallucci M, Puppo P, Fortunato P, Mauro M, Vincenzoni A, Zaccara A. Transurethral electrovaporization of the prostate with Vaportrode VE-B. Eur Urol 1996;29:450-5.
21. Shokeir AA, al-Sisi H, Farage YM, El-Maaboud MA, Saeed M, Mutabagani H. Transurethral prostatectomy: a prospective randomised study of conventional resection and electrovaporisation in benign prostatic hyperplasia. Br J Urol 1997; 80:570-4.
22. Hammadeh MY, Fowlis GA, Singh M, Philp T. Transurethral electrovaporization of the prostate - a possible alternative to transurethral resection: a one-year follow-up of a prospective randomized trial. Br J Urol 1998;81:721-5.
23. Hammedeh MY, Madaan S, Singh M, Philp T. 2-year follow-up of a prospective randomised trial of electrovaporisation versus resection of the prostate. Eur Urol 1998;34:188-92.
24. Gallucci M, Puppo P, Perachino M, Fortunato P, Muto G, Breda G, et al. Transurethral electrovaporisation of the prostate versus transurethral resection. Results of a multicentric randomised clinical study on 150 patients. Eur Urol 1998;33:359-364.
25. Barry MJ, Fowler FJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The Measurement Committee of the American Urological Association. The American Urological Association Symptom Index for Benign Prostatic Hyperplasia. J Urol 1992;148:1549-57.
26. Barry M, Fowler F, O'Leary M, Bruskewitz R, Holtgrewe H, Mebust W. Measuring disease-specific health status in men with benign prostatic hyperplasia. Med Care 1995;33:AS145-55.
27. Tavlov A, Ware J, Greenfield S, Nelson E, Peirin E, Zubcoff M. The Medical Outcomes Study: an application of methods for monitoring the results of medical care. JAMA 1989;262:925-30.
28. Brazier JE, Harper R, Jones NMB, O'Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire - new outcome measure for primary care. BMJ 1992; 305:160-4.
29. Emberton M, Neal DE, Black N, Fordham M, Harrison M, McBrien MP, et al. The effect of prostatectomy on symptom severity and quality of life. Br J Urol 1996;77:233-47.
30. Sonke GS, Heskes T, Verbeek AL, De La Rosette JA, Kiemeney LA. Prediction of BOO in men with LUTS using artificial neural networks. J Urol 2000;163:300-5.
31. McRae LP, Bottacini MR, Gleason DM. Noninvasive quantitative method for measuring isovolumetric bladder pressure and urethral resistance in the male: 1. Experimental validation of the theory. Neurourol Urodyn 1995;14:101-14.
32. Ukimura O, Kojima M, Inui E, Ochiai A, Hata Y, Watanabe M, et al. A statistical study of the American Urological Association symptom index for benign prostatic hyperplasia in participants of mass screening program for prostatic diseases using transrectal sonography. J Urol 1996;156:1673-8.
33. Lee AJ, Garraway WM, Simpson RJ. Pathophysiological relationships between LUTS and the prostate do not strengthen over time. Prostate 1998;37:5-9.
34. Jacobsen SJ, Jacobsen DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol 1997;158:481-7.
35. Chen S-S, Hong J-G, Hsiao Y-J, Chang LS. The correlation between clinical outcome and residual prostatic weight ratio after transurethral resection of the prostate for benign prostatic hyperplasia. Br J Urol Int 2000;85,79-82.
36. Green JSA, Bose P, Thomas DP, Thomas K, Clements R, Peeling WB, et al. How complete is a transurethral resection of the prostate? Br J Urol 1996; 77:398-400.
37. Patel A, Fuchs GJ, Gutierrez-Aceves J, Andrade-Perez F. Completeness and efficiency of prostate tissue removal: loop resection compared with a new operative technique of transurethral electrovaporization. Br J Urol Int 1999;84:43-9.
38. Aarnink RG, de la Rosette JJMCH, Debruyne FMJ, Wijkstra H. Formula-derived prostate volume determination. Eur Urol 1996; 29 399-402
39. Barry MJ, Williford WO, Chang Y, Machi M, Jones KM, Walker-Corkery E, et al. BPH Specific Health status measures in clinical research: how much change in the AUA Symptom Index and the BPH Impact Index is perceptible to the patient? J Urol 1995;154 1770-4.
40. Bryan NP, Byrne L, Hastie KJ, Anderson JB, Moore KTH, Chapple CR. A pilot study for a randomised controlled trial comparing the effectiveness, safety and cost-effectiveness of surgical treatments of the prostate. Br J Urol Int 1999;83:249-53.
41. Rohr LR. Incidental adenocarcinoma in transurethral resections of the prostate. Partial versus complete microscopic examination. Am J Surg Pathol 1987;11:53-8.